755 related articles for article (PubMed ID: 23863927)
1. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review).
Katoh M
Int J Mol Med; 2013 Oct; 32(4):763-7. PubMed ID: 23863927
[TBL] [Abstract][Full Text] [Related]
2. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
3. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenesis in cancer therapeutics: the magic bullet.
Oguntade AS; Al-Amodi F; Alrumayh A; Alobaida M; Bwalya M
J Egypt Natl Canc Inst; 2021 Jul; 33(1):15. PubMed ID: 34212275
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
6. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.
Ng EW; Adamis AP
Can J Ophthalmol; 2005 Jun; 40(3):352-68. PubMed ID: 15947805
[TBL] [Abstract][Full Text] [Related]
7. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production.
Litwin M; Radwańska A; Paprocka M; Kieda C; Dobosz T; Witkiewicz W; Baczyńska D
Mol Cell Biochem; 2015 Dec; 410(1-2):131-42. PubMed ID: 26314253
[TBL] [Abstract][Full Text] [Related]
8. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.
Wang Y; Wang L; Chen C; Chu X
Mol Cancer; 2018 Feb; 17(1):22. PubMed ID: 29415727
[TBL] [Abstract][Full Text] [Related]
9. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ; Baradaran B; Zamani F; Aghebati-Maleki L
Hum Antibodies; 2013; 22(1-2):15-9. PubMed ID: 24284305
[TBL] [Abstract][Full Text] [Related]
11. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy.
de Oliveira Dias JR; Rodrigues EB; Maia M; Magalhães O; Penha FM; Farah ME
Br J Ophthalmol; 2011 Dec; 95(12):1631-7. PubMed ID: 21546514
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
13. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
14. The Role of Angiogenesis-Inducing microRNAs in Vascular Tissue Engineering.
Ding MH; Lozoya EG; Rico RN; Chew SA
Tissue Eng Part A; 2020 Dec; 26(23-24):1283-1302. PubMed ID: 32762306
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor therapy in breast cancer: Molecular pathway, potential targets, and current treatment strategies.
Zhang M; Liu J; Liu G; Xing Z; Jia Z; Li J; Wang W; Wang J; Qin L; Wang X; Wang X
Cancer Lett; 2021 Nov; 520():422-433. PubMed ID: 34389434
[TBL] [Abstract][Full Text] [Related]
16. Sequential delivery of VEGF, FGF-2 and PDGF from the polymeric system enhance HUVECs angiogenesis in vitro and CAM angiogenesis.
Bai Y; Bai L; Zhou J; Chen H; Zhang L
Cell Immunol; 2018 Jan; 323():19-32. PubMed ID: 29111157
[TBL] [Abstract][Full Text] [Related]
17. VEGF and FGF-2: Promising targets for the treatment of respiratory disorders.
Laddha AP; Kulkarni YA
Respir Med; 2019 Sep; 156():33-46. PubMed ID: 31421589
[TBL] [Abstract][Full Text] [Related]
18. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.
Ferrara N
Semin Oncol; 2002 Dec; 29(6 Suppl 16):10-4. PubMed ID: 12516033
[TBL] [Abstract][Full Text] [Related]
19. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers.
Olejarz W; Kubiak-Tomaszewska G; Chrzanowska A; Lorenc T
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823989
[TBL] [Abstract][Full Text] [Related]
20. Genetic predictive biomarkers of anti-VEGF treatment response in patients with neovascular age-related macular degeneration.
Fauser S; Lambrou GN
Surv Ophthalmol; 2015; 60(2):138-52. PubMed ID: 25596882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]